Skip header and navigation

5 records – page 1 of 1.

Clinical psychology for trainees : foundations of science-informed practice

https://libcat.nshealth.ca/en/permalink/provcat27271
Page, Andrew C. --New York, NY: Cambridge University Press , 2006.
Available Online
View e-Book
Location
Online
Available Online
View e-Book
Author
Page, Andrew C
Other Authors
Stritzke, Werner G. K
Place of Publication
New York, NY
Publisher
Cambridge University Press
Date of Publication
2006
Physical Description
288 p.
ISBN
6610702497
Subjects (MeSH)
Psychotherapy - methods
Professional-Patient Relations
Psychology, Clinical - methods
Contents
Cover -- Half-title -- Title -- Copyright -- Dedication -- Contents -- Preface -- 1 A science-informed model of clinical psychology practice -- The scientist-practitioner model -- The aim of this book -- A science-informed model of clinical psychology practice -- Stakeholders in the practice of clinical psychology -- Presenting evidence to stakeholders -- 2 Relating with clients -- Empirical foundations of the therapeutic relationship -- Building a therapeutic alliance -- Relating with a client to build an alliance -- Encouraging, restating and paraphrasing -- Troubleshooting -- Summary -- 3 Assessing clients -- What is a mental disorder? -- Current diagnostic practices -- Diagnostic systems: the diagnostic and statistical manual of mental disorders (DSM) and the international classification of diseases (ICD) -- The DSM-IV -- Axis I: clinical disorders -- Axis II: personality disorders and mental retardation -- Axis III: general medical conditions -- Axis IV: psychosocial and environmental problems -- Axis V: global assessment of functioning (GAF) -- The ICD-10 -- Conducting a diagnostic interview -- Adapting diagnostic interviews for different client groups (children and the elderly) -- Screening for psychological symptoms -- Structured and semi-structured diagnostic interviews: adults -- Structured and semi-structured diagnostic interviews: children and adolescents -- Structured and semi-structured diagnostic interviews: older adults -- Mental status examination (MSE) -- Physical -- Emotional -- Cognitive -- Summary -- Limitations of diagnosis and future directions -- Additional assessment and testing -- 4 Linking assessment to treatment: case formulation -- Behavioural case formulation: functional analysis -- A case example -- Cognitive behavioural case formulation -- Problem list -- Core beliefs -- Precipitants and activating situations -- Working hypothesis -- Origins -- Treatment plan -- Predicted obstacles to treatment -- A model of case formulation -- A case example -- Presenting problems -- Precipitating variables -- Perpetuating cognitions and consequences -- Predisposing factors -- Provisional conceptualization -- Prescribed interventions -- Potential problems -- Case formulations in interpersonal psychotherapy -- A case example -- Deal with the depression -- Assess the interpersonal problems -- Negotiate a therapeutic contract -- Summary and contrast with CBT -- 5 Treating clients -- Behaviour therapy -- Contingency management -- Increasing desired behaviours -- Decreasing problem behaviours -- Differential reinforcement -- Contingency contracting -- Habit reversal -- Variables that influence performance -- Introducing new behaviours -- Maintenance of behaviours -- Self management -- Use behavioural contracting -- Modelling -- Dialectical behaviour therapy (DBT) -- Cognitive therapy -- Presenting a rationale for cognitive therapy -- Basics of interpersonal psychotherapy (IPT) -- Delivering empirically-supported treatments -- Example 1: exposure to feared stimuli -- Example 2: relaxation -- Summary -- 6 Group treatment -- Selecting a treatment programme -- Selecting patients for a group -- Assessment
Format
e-Book
Location
Online
Less detail

Diffuse Malignant Mesothelioma

https://libcat.nshealth.ca/en/permalink/provcat39016
Timothy Craig Allen, editor. --New York, NY: Springer , c2015.
Available Online
View e-Book
Location
Online
This volume is the most up-to-date text available on diffuse malignant mesothelioma and includes all the newest imaging modalities, immunohistochemical features, and ever-expanding information on the molecular characteristics of the cancer. In-depth chapters contain fully referenced text as well as detailed tables and images. While the primary audiences for this book are pathologists and pathology residents, the broad examination of diffuse malignant mesothelioma, including its epidemiology, ma…
Available Online
View e-Book
Other Authors
Allen, Timothy Craig
Responsibility
Timothy Craig Allen, editor
Place of Publication
New York, NY
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xi, 142 p. : 56 illus., 46 illus. in color)
ISBN
9781493923748
9781493923731 (print ed.)
Subjects (MeSH)
Mesothelioma - diagnosis
Mesothelioma - pathology
Abstract
This volume is the most up-to-date text available on diffuse malignant mesothelioma and includes all the newest imaging modalities, immunohistochemical features, and ever-expanding information on the molecular characteristics of the cancer. In-depth chapters contain fully referenced text as well as detailed tables and images. While the primary audiences for this book are pathologists and pathology residents, the broad examination of diffuse malignant mesothelioma, including its epidemiology, makes this book valuable to radiologists, surgeons, oncologists, and other clinical physicians and their residents as well. Written by experts in the field, Diffuse Malignant Mesothelioma is a concise yet comprehensive resource for clinicians involved in the management of one of the most widely recognized and feared cancers in the world.
Contents
Approaching the Diagnosis of Diffuse Malignant Mesothelioma -- Epidemiology -- Clinical and Radiologic Features -- Histology -- Immunohistochemistry -- Molecular Characteristics -- Therapy.
Format
e-Book
Location
Online
Less detail

Extreme Hepatic Surgery and Other Strategies : Increasing Resectability in Colorectal Liver Metastases

https://libcat.nshealth.ca/en/permalink/provcat41253
Eduardo de Santibañes, Victoria Ardiles, Fernando A. Alvarez, Virginia Cano Busnelli, Martin de Santibañes, editors. --Cham: Springer , 2017.
Available Online
View e-Book
Location
Online
This book describes the diagnoses; staging and management of patients with colorectal liver metastases initially considered unresectable and portrays the different strategies to increase resectability along with their tactics and tricks. Colorectal carcinoma is the third most commonly diagnosed cancer in the world and according to recent cancer statistics around 1.23 million patients are diagnosed each year. Of these patients, approximately 50% will develop liver metastases during the course of…
Available Online
View e-Book
Other Authors
de Santibañes, Eduardo
Ardiles, Victoria
Alvarez, Fernando A.
Busnelli, Virginia Cano
de Santibañes, Martin
Responsibility
Eduardo de Santibañes, Victoria Ardiles, Fernando A. Alvarez, Virginia Cano Busnelli, Martin de Santibañes, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
2017
Physical Description
1 online resource (xix, 383 pages) : 170 illus., 137 illus. in color
ISBN
9783319138961
9783319138954 (print ed.)
Subjects (MeSH)
Colorectal Neoplasms - complications
Liver Neoplasms - secondary
Liver Neoplasms - surgery
Abstract
This book describes the diagnoses; staging and management of patients with colorectal liver metastases initially considered unresectable and portrays the different strategies to increase resectability along with their tactics and tricks. Colorectal carcinoma is the third most commonly diagnosed cancer in the world and according to recent cancer statistics around 1.23 million patients are diagnosed each year. Of these patients, approximately 50% will develop liver metastases during the course of their disease and around 15-25% are found to have stage IV disease at diagnosis. Liver resection has been recognized as the treatment of choice for these patients, offering overall 5-year survival rates of up to 50-60% and the only hope for cure. However, at diagnosis only 10-20% of these patients are possibly amenable to surgical resection with curative intent. The possibility to achieve an R0 resection is many times limited by the amount and quality of the future liver remnant (FLR), being posthepatectomy liver failure (PHLF) the most feared and severe complication after major liver resections. With the years, diverse strategies have been developed with the intention to increase resectability by increasing the future liver remnant and/or reducing tumor size, e.g. ALPPS. Along with these techniques, associated surgeries are developed including multivisceral resections, which broadens even more the resectability for patients.
Contents
Part I: Global Patient Evaluation and Oncological Assessment -- 1. Liver Surgical Anatomy -- 2. Resectability Assessment with Diagnostic Imaging -- 3. Preoperative Evaluation of Liver Function -- 4. Imaging-Based Preoperative Planning -- 5. Choosing the Best Strategy -- Part II: Non-operative Multimodal Therapies -- 6. Conversion and Neoadjuvant Therapies -- 7. Portal Vein Embolization -- 8. Intra-Arterial Chemotherapy -- 9. Radioembolization -- Part III: Surgical Strategies -- 10. Anesthetic Management -- 11. Intraoperative Evaluation of Resectability -- 12. Vascular Control in Major Hepatic Resections -- 13. Two-Stage Liver Surgery -- 14. Two-Stage Liver Surgery with Portal Vein Occlusion -- 15. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS) -- 16. Parenchymal-Sparing Liver Resections -- 17. Combined Vascular Resections -- 18. Ex-Vivo Liver Surgery -- 19. The Role of Laparoscopy in Advanced Liver Disease -- 20. Liver Transplantation for Unresectable Disease -- Part IV: Management of Concomitant Extrahepatic Disease -- 21. Lung Metastases -- 22. Nodal Involvement -- 23. Peritoneal Metastases -- 24. Adjacent Organs Invasion: Multivisceral Resections -- Part V: Miscellany -- 25. Postoperative Complications and Their Management -- 26. Improving Quality of Life in Patients with Unresectable Disease.
Format
e-Book
Location
Online
Less detail

Historical Foundations of Liver Surgery

https://libcat.nshealth.ca/en/permalink/provcat45425
Thomas S. Helling, Daniel Azoulay. --Cham: Springer , c2020.
Available Online
View e-Book
Location
Online
For the surgeon of antiquity the liver has been an organ of mystery – and danger. Attempts to repair its wounds or remove tumors were fraught with hemorrhage and often a fatal outcome. Most forays were those to remove easily accessible tumors on the liver edge, but bleeding was a feared consequence still and surgeons wielded a plucky fortitude to take on even those. Not until the mid-20th Century were surgeons able to safely excise neoplasms that lay deep within the liver substance. Jean-Louis …
Available Online
View e-Book
Author
Helling, Thomas S.
Other Authors
Azoulay, Daniel
Responsibility
Thomas S. Helling, Daniel Azoulay
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2020
Physical Description
1 online resource (x, 147 p.) : 18 illus., 7 illus. in color
ISBN
9783030470951
9783030470944 (Print ed.)
9783030470968 (Print ed.)
Subjects (MeSH)
History of Medicine
Liver Diseases - surgery
Specialty
Gastroenterology
History of Medicine
Abstract
For the surgeon of antiquity the liver has been an organ of mystery – and danger. Attempts to repair its wounds or remove tumors were fraught with hemorrhage and often a fatal outcome. Most forays were those to remove easily accessible tumors on the liver edge, but bleeding was a feared consequence still and surgeons wielded a plucky fortitude to take on even those. Not until the mid-20th Century were surgeons able to safely excise neoplasms that lay deep within the liver substance. Jean-Louis Lortat-Jacob achieved notoriety in his famous Paris hepatectomy of 1951 but he was not the first. That distinction may have belonged to German Professor Walther Wendel in 1910 or to Japanese surgeon Ichio Honjo who reported his operation in 1950, but in Japanese. It was not picked up by the Western surgical community until 1955. Names such as Hugo Rex, James Cantlie, Jean-Louis Lortat-Jacob, Tôn Th?t Tùng, Jacques Hepp, Claude Couinaud, Henri Bismuth, Thomas Starzl, Roy Calne, and a host of others highlight the extraordinary curiosity, tenacity, and skill of those surgeons who broached unknown territory to master understanding and techniques of manipulation, resection, and transplantation that were formerly considered unapproachable by the surgical world.
Contents
Introduction -- The Bold Adventure of Lortat-Jacob -- The Liver: Impossible Salvations -- The Art of Operating -- Fin de Siècle: Marvels of the Age -- The World Wars and Hemorrhage Control -- A World-Wide Phenomenon: Liver Surgery in the Far East -- Beginning the Modern Era -- The Anatomists -- The French School -- Bach, Beethoven, and Brahms -- The Era of Transplantation -- Splitting the Soul -- On Regeneration -- Prometheus Renewed.
Format
e-Book
Location
Online
Less detail

Management of Chemotherapy-Induced Nausea and Vomiting : New Agents and New Uses of Current Agents

https://libcat.nshealth.ca/en/permalink/provcat40025
Rudolph M. Navari, editor. (1st ed.) --Cham: Springer International Publishing : Imprint: Adis , c2016.
Available Online
View e-Book
Location
Online
This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings. CINV is one of the most feared treatment related toxicities. Patient surveys for the past …
Available Online
View e-Book
Other Authors
Navari, Rudolph M
Responsibility
Rudolph M. Navari, editor
Edition
1st ed.
Place of Publication
Cham
Publisher
Springer International Publishing : Imprint: Adis
Date of Publication
c2016
Physical Description
1 online resource (viii, 181 p. : 17 illus., 9 illus. in color)
ISBN
9783319270166
9783319270142 (print ed.)
Subjects (MeSH)
Antiemetics - therapeutic use
Drug-Related Side Effects and Adverse Reactions
Nausea - chemically induced
Nausea - drug therapy
Neoplasms - drug therapy
Vomiting - chemically induced
Vomiting - drug therapy
Abstract
This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings. CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients' perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics. This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy.
Contents
1. Introduction -- 2. The Physiology and Pharmacology of Nausea and Vomiting Induced by Anti-Cancer Chemotherapy in Humans -- 3. First Generation 5HT-3 Receptor Antagonists -- 4. Second Generation Serotonin (5-HT3) Receptor Antagonist Palonosetron -- 5. The Role of Neurokinin-1 Receptor Antagonists in CINV -- 6. Olanzapine for the prevention of Chemotherapy-Induced Nausea and Vomiting -- 7. Gabapentin for the Prevention of CINV -- 8. Prevention of CINV in Patients Receiving High-Dose Multiple-Day Chemotherapy -- 9. Clinical Management of CINV -- 10. Treatment of Chemotherapy-Induced Nausea -- 11. Conclusions -- 12. Future Directions.
Format
e-Book
Location
Online
Less detail